InvestorsHub Logo
Followers 495
Posts 32125
Boards Moderated 0
Alias Born 03/12/2014

Re: None

Thursday, 05/16/2024 1:36:37 PM

Thursday, May 16, 2024 1:36:37 PM

Post# of 647604
NKGN

Keep an eye on this news today
CEO will release data about cancer tumor trial

Dr. Song’s presentation will cover a variety of important topics, including industry challenges in manufacturing autologous NK cells at scale, which has been successfully overcome by NKGen’s next-gen CMC manufacturing process in its production of its autologous NK cell therapy product, SNK01. In addition, Dr. Song will discuss the results from SNK01 treatment in combination with either immune checkpoint inhibitors in patients with advanced solid tumors, or, in combination with Erbitux in tyrosine kinase inhibitor-resistant non-small cell lung cance

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.